CoChat

Comparative Efficacy of Different Protein Supplements on Muscle Mass, Strength, and Physical Indices of Sarcopenia among Community-Dwelling, Hospitalized or Institutionalized Older Adults Undergoing Resistance Training: A Network Meta-Analysis of Randomized Controlled Trials

Open access

The DOI matches its Crossref record; 187 of the 188 references it cites were found in a registry or an index.

Abstract

Aging-related sarcopenia exerts harmful impacts on muscle mass, strength, and physical mobility. Protein supplementation has been demonstrated to augment efficacy of resistance training (RT) in elderly. This study compared the relative effects of different protein supplements on muscle mass, strength, and mobility outcomes in middle-aged and older individuals undergoing RT. A comprehensive search of online databases was performed to identify randomized controlled trials (RCTs) examining the efficacy of protein supplement plus RT in untrained community-dwelling adults, hospitalized, or institutionalized residents who suffered acute or chronic health conditions. Network meta-analysis (NMA) was performed using a frequentist method for all analyses. Treatment effects for main outcomes were expressed as standard mean difference (SMD) with 95% confidence interval (CI). We used the surface-under-the cumulative-ranking (SUCRA) scores to rank probabilities of effect estimation among all identified treatments. Meta-regression analyses were performed to identify any relevant moderator of the treatment efficacy and results were expressed as β with 95% credible interval (CrI). We finally included 78 RCTs (5272 participants) for analyses. Among the six protein sources identified in this NMA, namely whey, milk, casein, meat, soy, and peanut, whey supplement yielded the most effective treatments augmenting efficacy of RT on muscle mass (SMD = 1.29, 95% CI: 0.96, 1.62; SUCRA = 0.86), handgrip strength (SMD = 1.46, 95% CI: 0.92, 2.00; SUCRA = 0.85), and walking speed (SMD = 0.73, 95% CI: 0.39, 1.07; SUCRA = 0.84). Participant’s health condition, sex, and supplementation dose were significant factors moderating the treatment efficacy on muscle mass (β = 0.74; 95% CrI: 0.22, 1.25), handgrip strength (β = −1.72; 95% CrI: −2.68, −0.77), and leg strength (β = 0.76; 95% CrI: 0.06, 1.47), respectively. Our findings suggest whey protein yields the optimal supplements to counter sarcopenia in older individuals undergoing RT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu16070941

Cites

187 of 187 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 RRISMA flow diagram of study selection. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
Figure 1 RRISMA flow diagram of study selection. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.CC BY · PubMed Central
Figure 2 Risk of bias graph crossing trials.
Figure 2 Risk of bias graph crossing trials.CC BY · PubMed Central
Figure 3 Network diagram illustrating the interconnections among different treatment arms for muscle mass. Each node represents a treatment arm, and the size of the node is proportional to the number of participants assigned to the specific treatment. The thickness of each line is proportional to the number of direct comparisons between arms denoted on the line. RT, resistance training.
Figure 3 Network diagram illustrating the interconnections among different treatment arms for muscle mass. Each node represents a treatment arm, and the size of the node is proportional to the number of participants assigned to the specific treatment. The thickness of each line is proportional to the number of direct comparisons between arms denoted on the line. RT, resistance training.CC BY · PubMed Central
Figure 4 Relative efficacy of treatment regimens on muscle mass gain during an overall follow-up duration. Each point estimate (square) presents the network combined effect (SMD) on the outcome measure relative to RC, with the 95% CI (horizontal line). SMD, standardized mean difference; CI, confidence interval; SUCRA, surface under the cumulative ranking curve; RT, resistance training; RC, regular care.
Figure 4 Relative efficacy of treatment regimens on muscle mass gain during an overall follow-up duration. Each point estimate (square) presents the network combined effect (SMD) on the outcome measure relative to RC, with the 95% CI (horizontal line). SMD, standardized mean difference; CI, confidence interval; SUCRA, surface under the cumulative ranking curve; RT, resistance training; RC, regular care.CC BY · PubMed Central
Figure 5 Network diagram illustrating the interconnections among different treatment arms for muscle strength. Each node represents a treatment arm, and the size of the node is proportional to the number of participants assigned to the specific treatment. The thickness of each line is proportional to the number of direct comparisons between arms denoted on the line. RT, resistance training.
Figure 5 Network diagram illustrating the interconnections among different treatment arms for muscle strength. Each node represents a treatment arm, and the size of the node is proportional to the number of participants assigned to the specific treatment. The thickness of each line is proportional to the number of direct comparisons between arms denoted on the line. RT, resistance training.CC BY · PubMed Central
Figure 6 Relative efficacy of treatment regimens on muscle strength during an overall follow-up duration. Each point estimate (square) presents the network combined effect (SMD) on the outcome measure relative to RC, with the 95% CI (horizontal line). SMD, standardized mean difference; CI, confidence interval; SUCRA, surface under the cumulative ranking curve; RT, resistance training; RC, regular care.
Figure 6 Relative efficacy of treatment regimens on muscle strength during an overall follow-up duration. Each point estimate (square) presents the network combined effect (SMD) on the outcome measure relative to RC, with the 95% CI (horizontal line). SMD, standardized mean difference; CI, confidence interval; SUCRA, surface under the cumulative ranking curve; RT, resistance training; RC, regular care.CC BY · PubMed Central
Figure 7 Network diagram illustrating the interconnections among different treatment arms for physical mobility. Each node represents a treatment arm, and the size of the node is proportional to the number of participants assigned to the specific treatment. The thickness of each line is proportional to the number of direct comparisons between arms denoted on the line. RT, resistance training; SPPB, Short Physical Performance Battery.
Figure 7 Network diagram illustrating the interconnections among different treatment arms for physical mobility. Each node represents a treatment arm, and the size of the node is proportional to the number of participants assigned to the specific treatment. The thickness of each line is proportional to the number of direct comparisons between arms denoted on the line. RT, resistance training; SPPB, Short Physical Performance Battery.CC BY · PubMed Central
Figure 8 Relative efficacy among treatment regimens on changes in physical mobility scores during an overall study time. Each point estimate (square) presents the network combined effect on the specific outcome measure, with the 95% CI (horizontal line). The positive results indicate favorable efficacy of the treatment regimen compared to RC. The blue-colored point represents the highest probability of effects among all treatment regimens. Std, standardized; CI, confidence interval; RT, resistance training; SPPB, Short Physical Performance Battery; RC, regular care.
Figure 8 Relative efficacy among treatment regimens on changes in physical mobility scores during an overall study time. Each point estimate (square) presents the network combined effect on the specific outcome measure, with the 95% CI (horizontal line). The positive results indicate favorable efficacy of the treatment regimen compared to RC. The blue-colored point represents the highest probability of effects among all treatment regimens. Std, standardized; CI, confidence interval; RT, resistance training; SPPB, Short Physical Performance Battery; RC, regular care.CC BY · PubMed Central
Figure 9 Participant compliance and side effects of treatment regimens. Data concerning treatment-related (A) withdrawals and (B) adverse events were pooled using inverse variance weighting methods. Each point estimate (square) presents the network combined effect (OR) of the indicated treatment arm relative to RC, with the 95% CI (horizontal line). OR, odds ratio; CI, confidence interval; RT, resistance training.
Figure 9 Participant compliance and side effects of treatment regimens. Data concerning treatment-related (A) withdrawals and (B) adverse events were pooled using inverse variance weighting methods. Each point estimate (square) presents the network combined effect (OR) of the indicated treatment arm relative to RC, with the 95% CI (horizontal line). OR, odds ratio; CI, confidence interval; RT, resistance training.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 5

  1. Chang, 2019, Effects of resistance training combined with nutritional intervention on alleviating sarcopenia in the elderly, Electron. J. Pract. Clin. Nurs. Sci., 4, 48
  2. Chen, 2017, Effects of fortified nutrition combining with resistance exercise on physical function and activity of daily living for elderly patients with sarcopenia, J. Nurs. Sci., 32, 8
  3. He, 2022, Observation on the Clinical Effect of Dietary Nutrition Intervention Combined with Anti-resistance Training in Elderly Male Patients with Sarcopenia, Smart Healthc., 8, 44
  4. Tang, 2020, Analysis of the Clincal Effect ofDietary Nutrition Intervention Combined with Resistance Training on the Cognitive Function of Elderly Male Patients with Sarcopenia, Progr. Mod. Biomed., 20, 2698
  5. Zhao, 2022, Effect of health education and whey protein supplementation combined with resistance exercise on the intervention of middle—Aged and elderly people with sarcopenia, J. Clin. Exp. Med., 12, 90

Cited by

See all 45

Metadata

Authors
Liao, C.-D., Huang, S.-W., Chen, H.-C., Huang, M.-H., Liou, T.-H., & Lin, C.-L.
Affiliations
  • Taipei Medical University-Shuang Ho Hospital (TW)
  • Department of Biochemistry, University of Washington, Seattle, WA 98015, USA
Corresponding author
Lin, Che-Li
Venue
Nutrients
Publisher
MDPI AG
Published
2024-03-25
Volume
16
Issue
7
Pages
941
ISSN
2072-6643 (ISSN-L)
OpenAlex
W4393142008
Cited by
45
References
188
Citations by year
2026: 22 · 2025: 19 · 2024: 4
FWCI
2.57
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare, Taiwan (112TMU-SHH-35, TMU110-AE1-B10)
  • Taipei Medical University (112TMU-SHH-35, TMU110-AE1-B10)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords
sarcopenia, protein supplementation, resistance training, whey protein, casein, soy protein, peanut protein, milk protein, muscle mass, grip strength, walking speed, older adults, hospitalized older adults, institutionalized elderly, leg strength, physical mobility, dose-response relationship, sex differences, community-dwelling adults, middle-aged adults
MeSH terms
Network Meta-Analysis, Aged, Aged, 80 and over, Dietary Proteins, Female, Hospitalization, Humans, Male, Middle Aged, Muscles, Randomized Controlled Trials as Topic, Treatment Outcome, Muscle, Skeletal, Dietary Supplements, Muscle Strength, Resistance Training, Sarcopenia, Independent Living

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.